Novelix Pharmaceuticals Shareholders Approve Appointment of Sridevi Belide as Non-Executive Director

Novelix Pharmaceuticals Limited has announced that its shareholders have approved the appointment of Ms. Sridevi Belide as Non-Executive Non-Independent Director during an Extraordinary General Meeting (EGM) held on January 9, 2026. The company, formerly known as Trimurthi Limited, communicated this development to BSE Limited on January 10, 2026.

Appointment Details

The key details of Ms. Belide's directorial appointment are outlined in the company's regulatory filing:

Parameter	Details
Director Name	Ms. Sridevi Belide
DIN	10455373
Position	Non-Executive Non-Independent Director
Effective Date	October 23, 2025
Approval Date	January 9, 2026 (EGM)
Relationship	Belongs to promoter group

Regulatory Compliance

Novelix Pharmaceuticals has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that Ms. Belide is not related to any existing director and belongs to the promoter group of the company.

The filing also stated that Ms. Sridevi Belide is not debarred from holding the office of Director by any SEBI order or any other regulatory authority, ensuring compliance with BSE circular requirements.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-3.71%	-5.56%	+6.21%	+29.38%	+137.23%	+1,032.21%

Meeting Participation and Voting Details

The EGM witnessed significant shareholder participation despite being conducted virtually. As of the cutoff date of January 02, 2026, the company had 3,085 total shareholders. The meeting saw attendance from 64 participants through video conferencing, including 3 from the promoter and promoter group category and 61 from the public category.

Parameter:	Details
Total Shareholders (Cutoff Date):	3,085
Meeting Date:	January 09, 2026
Meeting Time:	03:30 P.M. IST
Mode:	Video Conferencing/OAVM
VC Attendees - Promoter Group:	3
VC Attendees - Public:	61

Resolution Results and Voting Pattern

Both resolutions presented at the EGM received unanimous approval from shareholders. The voting process included remote e-voting prior to the meeting and e-voting during the meeting, with a total of 86 shareholders participating in the electronic voting process.

Resolution 1: Issue of Equity Shares on Preferential Basis (Special Resolution)

Category:	Shares Held	Votes Polled	Polling %	Votes in Favour
Promoter and Promoter Group:	8,822,733	8,422,733	95.47%	8,422,733
Public-Non Institutions:	7,318,267	1,724,405	23.56%	1,724,405
Total:	16,141,000	10,147,138	62.87%	10,147,138

Resolution 2: Appointment Confirmation (Ordinary Resolution)

The second resolution concerned the confirmation of Ms. Sridevi Belide (DIN: 10455373) as Additional Director and Non-Executive Non-Independent Director of the company. This resolution also received identical voting results with complete unanimity.

Voting Outcome:	Details
Total Votes Cast:	10,147,138
Votes in Favour:	10,147,138 (100%)
Votes Against:	0 (0%)
Resolution Status:	Passed

Scrutinizer's Report and Compliance

Bharat Khaniwal & Co., Practicing Company Secretaries, served as the appointed scrutinizer for the e-voting process. Bharat Khaniwal (Membership Number 29035, Certificate of Practice Number 27989) conducted the scrutiny of both remote e-voting and e-voting during the meeting.

The remote e-voting period commenced on January 06, 2026, at 09:00 A.M. IST and concluded on January 08, 2026, at 05:00 P.M. IST. The company utilized the e-voting facility provided by Central Depository Services (India) Limited (CDSL) for the electronic voting process.

Corporate Information and Communication

The voting results have been uploaded in XBRL format on the BSE portal as required under regulatory compliance. Venkateshwarlu Pulluru, Whole-time Director (DIN: 02076871), signed the communication to BSE Limited regarding the voting results.

The company, headquartered in Hyderabad, Telangana, operates under CIN: L67120TG1994PLC018956 with BSE scrip code 536565 and security ID NOVELIX. The successful completion of the EGM with unanimous approval demonstrates strong shareholder confidence in the company's strategic decisions and leadership appointments.